Comment
Comments on the FDA’s Draft Guidance for Industry, Presenting Risk Information In Prescription Drug and Medical Device Promotion
In comments on an FDA draft guidance document for drug industry advertising, CEI challenged the agency to bring its “1960s approach to prescription drug advertising…
Comment
Letter to Securities and Exchange Commission: Reforming Shareholder Director Nominations
Thank you for allowing me the opportunity to submit comments on the proposed rule governing shareholder nominations of corporate directors on behalf of the…
Letters
Coalition Letter on Optional Federal Chartering
Full Letter Available in Word As Congress moves towards a debate over sweeping reform of the nation’s financial regulations, we urge you to…
Comment
Comments on the Federal Communications Commission Report ‘A National Broadband Plan for our Future’
The Commission’s record of alleged “regulatory restraint” toward the telecommunications sector over the past 13 years has come under fire by a number of commenters…
Comment
Comments on “Charting the Course for Ocean Science” submitted to the Office of Science and Technology Policy
Re: Update of Charting the Course for Ocean Science in the United States for the Next Decade: An Ocean Research Priorities Plan and Implementation Strategy…
Letters
Coalition Letter on TARP Transparency
Full Document Avalible in PDF On behalf of the millions of taxpayers represented by our respective organizations, we write to urge your support…